A detailed cost analysis of in vitro fertilization and intracytoplasmic sperm injection treatment

Fertility and Sterility

Volumn 89, Issue 2, 2008, Pages 331-341

  Bouwmans, Clazien A M ^a   Lintsen, Bea M E ^b   Eijkemans, Marinus J C ^a   Habbema, J Dik F ^a   Braat, Didi D M ^b   Hakkaart, Leona ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cost estimates; cryopreservation; diagnostic work up; ICSI; IVF

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; CRYOPRESERVATION; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HEALTH CARE COST; HORMONAL REGULATION; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; OOCYTE RETRIEVAL; PREGNANCY; PRIORITY JOURNAL;

COSTS AND COST ANALYSIS; CRYOPRESERVATION; EMBRYO TRANSFER; FEMALE; FERTILITY; FERTILIZATION IN VITRO; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; MALE; OOCYTE RETRIEVAL; OVULATION INDUCTION; PREGNANCY; PREGNANCY TESTS; SPERM INJECTIONS, INTRACYTOPLASMIC;

EID: 38949148274     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.03.003     Document Type: Article

References (22)

1. Kremer J., Beekhuizen W., Bots R., Braat D., van Dop P.A., Jansen C., et al. Results of in vitro fertilization in the Netherlands, 1996-2000. [in Dutch]. Ned Tijdschr Geneeskd 146 (2002) 2358-2363
2. Collins J. An international survey of the health economics of IVF and ICSI. Hum Reprod 8 (2002) 265-277
3. Goverde A., McDonnell J., Vermeiden J., Schats R., Rutten F., and Schoemaker J. Intrauterine insemination or in-vitro fertilisation in idiopathic subfertility and male subfertility: a randomised trial and cost-effectiveness analysis. Lancet 355 (2000) 13-18
4. Oostenbrink J.B., Bouwmans C.A.M., Koopmanschap M.A., and Rutten F.F.H. Handleiding voor kostenonderzoek, methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg (2004), College voor zorgverzekeringen, Diemen, the Netherlands
5. In: van Loenen A. (Ed). Farmacotherapeutisch Kompas (2003), Bohn Stafleu van Loghum, Houten, the Netherlands
6. Bergh T., and Lundkvist O. Clinical complications during in-vitro fertilization treatment. Hum Reprod 7 (1992) 625-626
7. Kremer J. National IVF figures 2004. Available at: http://www.nvog.nl/files/ivfcijfers2004perkliniek.pdf.
8. Eijkemans M., Polander S., Mulders A., Laven J., Habbema J., and Fauser B. Individualized cost-effective conventional ovulation induction treatment in normogonadotrophic anovulatory infertility (WHO group 2). Hum Reprod 20 (2005) 2830-2837
9. Gerris J., De Sutter P., De Neubourg D., Van Royen E., Vander Elst J., Mangelschots K., et al. A real-life prospective health economic study of elective single embryo transfer versus two-embryo transfer in first IVF/ICSI cycles. Hum Reprod 19 (2004) 917-923
10. Granberg M., Strandell A., Thorburn J., Daya S., and Wikland M. Economic evaluation of infertility for tubal disease. J Assist Reprod Genet 20 (2003) 301-308
11. Hatoum H., Keye W., Marrs R., Walton S., and Marshall D. A Markov model of the cost-effectiveness of human derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical data. Fertil Steril 83 (2005) 804-807
12. Kansal-Kalra S, Milad M, WA WG. In vitro fertilization (IVF) versus gonadotropins followed by IVF as treatment for primary infertility: a cost-based decision analysis. Fertil Steril 2005;84:600-4.
13. Kjellberg A., Carllson P., and Bergh C. Randomized single versus double embryo transfer: obstetric and paediatric outcome and a cost-effectiveness analysis. Hum Reprod 21 (2006) 210-216
14. Koivurova S., Hartikainen A., Gissler M., Hemminki E., Klemetti R., and Jarvelin M. Health care costs resulting from IVF: prenatal and neonatal periods. Hum Reprod 19 (2004) 2798-2805
15. Kovacs P., Matyas S., Bernard A., and Kaali S. Comparison of clinical outcome and costs with CC + gonadotropins and gnrha + gonadotropins during Ivf/ICSI cycles. J Assist Reprod Genet 21 (2004) 197-202
16. Lloyd A., Kennedy R., Hutchinson J., and Sawyer W. Economic evaluation of highly purified menotropin compared with recombinant follicle-stimulating hormone in assisted reproduction. Fertil Steril 80 (2003) 1108-1113
17. Lukassen H., Braat D., Wetzels A., Zielhuis G., Adang E., Scheenjes E., et al. Two cycles with single embryo transfer versus one cycle with double embryo transfer: a randomized controlled trial. Hum Reprod 20 (2005) 702-708
18. Silverberg K., Daya S., Auray J., Duru G., Ledger W., Wikland M., et al. Analysis of the cost effectiveness of recombinant versus urinary follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection programs in the United States. Fertil Steril 77 (2002) 107-113
19. Strandell A., Lindhard A., and Eckerlund I. Cost-effectiveness analysis of salpingectomy prior to IVF, based on randomized controlled trial. Hum Reprod 20 (2005) 3284-3292
20. Sykes D., Out H., Palmer S., and van Loon J. The cost-effectiveness of IVF in the UK: a comparison of three gonadotrophin treatments. Hum Reprod 16 (2001) 2557-2562
21. Fiddelers A., van Montfoort A., Dirksen C., Dumoulin J., Land J., Dunselman G., et al. Single versus double embryo transfer: cost-effectiveness analysis alongside a randomized clinical trial. Hum Reprod 21 (2006) 2090-2097
22. ESHRE, Andersen A., Gianaroli L., Felberbaum R., de Mouzon J., and Nygren K. Assisted reproductive technology in Europe, 2002. Results generated from European registers by ESHRE. The European IVF-monitoring programme (EIM) for the European Society of Human Reproduction and Embryology (ESHRE). Hum Reprod 21 (2006) 1680-1697